Share: Share on Facebook Share on Twitter Share on LinkedIn I recommend visiting to read:%0A%0A {0} %0A%0A {1}
22q1-lifesciencesupdate-mobilehero 22q1-lifesciencesupdate-hero


Life Sciences Update: October 2022


Following extraordinary investment, expansion, and innovation in 2021, the life sciences industry is poised for further growth and consistent demand in the years ahead.
Going forward, capitalising on the latest trends in technology will be more critical than ever as these advancements are continuously reshaping the way we research, develop, test, go to market and analyse data in life sciences. Even though its trajectory is intact, the sector is not immune, however, to overarching economic factors like inflation, higher interest rates and tightening capital markets, which are impacting investors and life sciences companies looking to occupy space within a tight budget.

Life Sciences Market Summaries 

Select each market on the map below to view an in-depth life sciences market summary for that city.


Read the full report and explore the market-by-market analysis.

Real Estate Fundamentals Remain Strong 

The life sciences sector has experienced outsized growth in the last seven years.

UK life sciences rents have grown 63% since 2017, on par with U.S. markets. Growth has slowed in some markets but remains above 2019 pre-pandemic levels.

U.S. asking rents are 67% higher, on average, than in 2015, and inventory has grown in tandem by 29% across the markets tracked by Cushman & Wakefield Research.

Flow of Funding 

The global life sciences venture capital funding market experienced a slowdown in the first half of 2022 relative to the same period in 2021.

Future Demand 

The flow of venture capital into the life sciences sector has accelerated the growth of new companies with seed and early-stage companies still experiencing significant momentum.

For the markets tracked by Cushman & Wakefield, 55.20% of the VC deals into life science companies with a UK presence through to the end of August 2022, involved pre or early-stage VC deals, with an average deal size across all VC investments of £11.65 million.


This 2022 Life Sciences Update webinar breaks down the current trends in the life sciences industry by exploring:

  • Strength of real estate fundamentals
  • The ongoing labor crunch
  • How the economic slowdown is impacting the industry
  • The continued flow of funding into life sciences
    Subscribe to Life Sciences Insights
    Get the latest in Cushman & Wakefield's Life Sciences research and commentary.
    Subscribe Learn More



    Jamie Renison - London
    Jamie Renison

    Head of Life Sciences Agency, UK
    London, United Kingdom

    +44 207 152 5421

    Download VCard

    Michael Aston
    Michael Aston

    Head of Life Sciences, UK
    London, United Kingdom

    +44 (7736) 125220

    Download VCard

    Related insights


    Does your building qualify for a life sciences conversion?

    Interest in converting assets for life sciences use is growing amongst building owners. Cushman & Wakefield’s Project & Development Services team developed basic building performance criteria based on the minimum standards that life sciences companies typically require. 
    Eric Giles • 18/07/2023
    Life Science

    Challenges for Life Sciences Projects Means Early Engagement of Project Managers

    Persistent challenges continue to impact costs, material lead times and project timelines across all life sciences projects.
    Jason D'Orlando • 30/06/2023

    Life Science Update: Finding Talent and Fostering New Ideas

    Encouraging collaboration to formulate new ideas and creating access to skilled talent remain priorities for life sciences companies. Among current life science industry trends, there are several hot locations for the life sciences, as well as a focus on amenities that spark ‘spontaneous interactions’.
    Rachel Park • 19/10/2022

    Interested in learning more?

    Get in touch and we can assist with any additional information you need.
    With your permission we and our partners would like to use cookies in order to access and record information and process personal data, such as unique identifiers and standard information sent by a device to ensure our website performs as expected, to develop and improve our products, and for advertising and insight purposes.

    Alternatively click on More Options and select your preferences before providing or refusing consent. Some processing of your personal data may not require your consent, but you have a right to object to such processing.

    You can change your preferences at any time by returning to this site or clicking on Cookies.
    Agree and Close
    These cookies ensure that our website performs as expected,for example website traffic load is balanced across our servers to prevent our website from crashing during particularly high usage.
    These cookies allow our website to remember choices you make (such as your user name, language or the region you are in) and provide enhanced features. These cookies do not gather any information about you that could be used for advertising or remember where you have been on the internet.
    These cookies allow us to work with our marketing partners to understand which ads or links you have clicked on before arriving on our website or to help us make our advertising more relevant to you.
    Agree All
    Reject All